Gujarat Terce Laboratories Limited (BSE: 524314)
Health Care · Pharmaceuticals · IN
Rs37.62
-2.79% today · -15.3% 1Y
Gujarat Terce Laboratories Limited (BSE: 524314) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.06M.
Over the last twelve months the share price has lost 15.3%, trading between 29.00 and 59.78.
Tweenvest scores Gujarat Terce Laboratories Limited across four factors: quality 79/100, value 43/100, growth 9/100. Its strongest factor is quality.
524314 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.06M
- Revenue (TTM)
- $4.83M
- P/E
- 13.95
- EPS
- 2.70
- Dividend yield
- —
- Beta (5Y)
- 0.93
- 52-week high
- Rs59.78
- 52-week low
- Rs29.00
- Avg volume (3M)
- —
- Shares outstanding
- 7.79M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,247.70 | +0.06% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $271.02 | -0.74% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $151.20 | +0.36% |
| Roche Holding AGSWX: ROP | $368.80B | CHF371.10 | +0.19% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.32 | +0.18% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.02 | +0.18% |
Figures last refreshed Aug 18, 2026.